Lin Chen

机构：Shenzhen Chronic Disease Prevention Center, Shenzhen Nanshan Center for Chronic Disease Control · ORCID：0000-0003-4509-0823

发表论文 31 篇 · 总被引 443 次 · h-index 12

代表论文

• Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy (2023 · Phytomedicine · 被引 71)
• Leveraging electronic health records data to predict multiple sclerosis disease activity (2021 · Annals of Clinical and Translational Neurology · 被引 32)
• Nuciferine Alleviates High-Fat Diet- and ApoE –/– -Induced Hepatic Steatosis and Ferroptosis in NAFLD Mice via the PPARα Signaling Pathway (2024 · Journal of Agricultural and Food Chemistry · 被引 21)
• Thymosin β4 and Actin: Binding Modes, Biological Functions and ClinicalApplications (2022 · Current Protein and Peptide Science · 被引 21)
• Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway (2024 · Phytomedicine · 被引 17)
• Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naïve first-episode schizophrenia (2021 · Psychiatry Research · 被引 17)